CCL4 and intraepithelial neoplasia: Accordingly, MIP-1β/CCL4 expressions were higher in lesions from patients with PCa and with intraepithelial neoplasia (PIN) lesions than in nonneoplastic prostate patients [49], but to our knowledge, no reports are available regarding MIP-1β/CCL4 plasma levels in PCa patients.